# US 2015/0147413 A1 · Methods for Treating a Neoplastic Disease in a Subject Using Inorganic Selenium-Containing Compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0147413 A1
- Document ID: US20150147413A1
- Status: Published application
- Kind: A1
- Application number: 14/553,866
- Filed: 2014-11-25
- Published: 2015-05-28
- Earliest claimed: 2003-11-14
- Assignees: The Board of Trustees of the Leland Stanford Junior University
- Applicants: The Board of Trustees of the Leland Stanford Junior University
- Inventors: SUSAN J. KNOX; BRYAN HUSBECK
- Web page: https://patentgrep.com/patent/US20150147413A1

## CPC

- A61K 33/04: Sulfur, selenium or tellurium; Compounds thereof
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61N 5/1001: {using radiation sources introduced into or applied onto the body; brachytherapy}
- A61P 13/08: of the prostate
- A61P 35/00: Antineoplastic agents
- A61N 2005/1098: {Enhancing the effect of the particle by an injected agent or implanted device}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention features methods and selenium-containing compositions for treating a neoplastic disease in a subject. In particular, the invention features methods for enhancing sensitivity of a tumor to cancer therapy by treating the tumor with an inorganic selenium-containing (iSe) compound and with a cancer therapy, particularly a cancer therapy that also affects the cellular redox status of a tumor cell (e.g., radiation).

## Claims

### Claim 1

A method of treating a neoplastic disease in a subject, the method comprising:
administering to a subject having a tumor a pharmaceutically acceptable salt of an inorganic selenium-containing compound (iSe compound) in an amount effective to alter a reduction-oxidation state of a tumor cell toward oxidation; and
administering a cancer therapy other than an iSe compound to the subject;
wherein the neoplastic disease in the subject is treated.

### Claim 2 (depends on 1)

The method of claim 1, wherein the iSe compound is inorganic selenite.

### Claim 3 (depends on 1)

The method of claim 1, wherein the cancer therapy is administered after administering the iSe compound.

### Claim 4 (depends on 1)

The method of claim 1, wherein the neoplastic disease is prostate cancer.

### Claim 5 (depends on 1)

The method of claim 1, wherein the cancer therapy is radiation therapy.

### Claim 6 (depends on 5)

The method of claim 5, wherein the radiation therapy is external beam radiation therapy, brachytherapy or systemically targeted radiation.

### Claim 7 (depends on 1)

The method of claim 1, wherein the cancer therapy is a chemotherapeutic agent.

### Claim 8 (depends on 1)

The method of claim 1, wherein said administering of the iSe compound is oral, intravenous, tumor targeted, intratumoral, or peritumoral.

### Claim 9 (depends on 1)

The method of claim 1, wherein the iSe compound is administered for a time sufficient for metabolism of the iSe compound prior to administering the cancer therapy.

### Claim 10

A method of enhancing sensitivity of a tumor in a subject to a cancer therapy, the method comprising:
administering to a subject having a tumor a pharmaceutically acceptable salt of an inorganic selenium-containing (iSe) compound in an amount effective to sensitize the tumor to a cancer therapy; and
administering the cancer therapy to the subject;
wherein administration of the iSe compound is effective to enhance sensitivity of the tumor to the cancer therapy.

### Claim 11 (depends on 10)

The method of claim 10, wherein inorganic selenium-containing compound is inorganic selenite.

### Claim 12 (depends on 11)

The method of claim 11, wherein the cancer therapy is a reactive oxygen species (ROS)-inducing therapy.

### Claim 13 (depends on 12)

The method of claim 12, wherein the ROS-inducing cancer therapy is a radiotherapy.

### Claim 14 (depends on 12)

The method of claim 12, wherein the ROS-inducing cancer therapy is a chemotherapeutic drug or a biological response modifier.

### Claim 15

A method of treating prostate cancer, the method comprising:
administering to a subject having prostate cancer a pharmaceutically acceptable salt of an inorganic selenite; and
administering a cancer therapy other than inorganic selenite to the subject;
wherein administering the inorganic selenite and the cancer therapy provides for a synergistic effect in prostate cancer cell growth inhibition to treat the prostate cancer.

### Claim 16 (depends on 15)

The method of claim 15, wherein the cancer therapy is a reactive oxygen species (ROS)-inducing therapy.

### Claim 17 (depends on 16)

The method of claim 16, wherein the ROS-inducing cancer therapy is a radiotherapy.

### Claim 18 (depends on 16)

The method of claim 16, wherein the ROS-inducing cancer therapy is a chemotherapeutic drug or a biological response modifier.

### Claim 19 (depends on 17)

The method of claim 17, wherein the radiotherapy comprises external radiation therapy, brachytherapy (internal radiation therapy), or systemically targeted radiation.

### Claim 20 (depends on 13)

The method of claim 13, wherein the radiotherapy comprises external radiation therapy, brachytherapy (internal radiation therapy), or systemically targeted radiation.
